Artificial intelligence is gradually moving from laboratories into hospitals, clinics, and people's daily lives; however, transforming technological breakthroughs into reliable medical services remains a complex challenge. At the China International Fair for Trade in Services (CIFTIS) in Beijing in 2026, topics related to AI-based healthcare and elderly care were actively discussed.
Technologies such as AI-based health management platforms and intelligent nurse robots are already being used to reduce the burden caused by nursing staff shortages and improve services for the older generation. Nevertheless, industry representatives also pointed out persistent difficulties.
As medical AI rapidly develops globally, the overarching issue is the gap between AI's technical capabilities and what can be safely and effectively implemented in healthcare. International cooperation can bridge this gap by combining technological expertise, clinical experience, investment, funding, and practical application scenarios.
From Healthcare Dialogue to AI Cooperation
China and the United States have a long history of dialogue and interaction in the healthcare sector. Recently, artificial intelligence has become an increasingly prominent part of these discussions. At the 11th China-US Health Dialogue held in Hangzhou in June, experts from both countries examined biomedical innovations, implementation science, the application of AI in healthcare systems, and cardiovascular disease prevention.
Participants also explored avenues for closer partnership, including the use of digital health and AI to improve chronic disease management. The significance of this discussion reflects a broader shift in medicine: technology is increasingly being applied not only for diagnosing and treating diseases but also for assisting people with health monitoring, managing chronic conditions, and making more informed decisions in daily life.
Cooperation is Already Taking Shape
In November 2025, GE HealthCare and Damo Academy (Alibaba) signed a framework agreement. The parties announced their intention to combine GE HealthCare's expertise in medical imaging with Damo Academy's AI capabilities to develop comprehensive solutions that ensure more accurate and effective diagnostics.
This collaboration focuses on integrating AI with non-contrast CT scans to detect various types of cancer, acute conditions, and chronic diseases. Furthermore, both sides plan to work on optimizing models and developing products to transfer AI technologies from the research stage to clinical application.
As China and the United States continue to explore how AI can transform healthcare—from medical imaging and chronic disease management to preventive care and daily medical services—their priorities are increasingly aligning in the same areas. This opens opportunities for the two countries to combine their strengths in technology, medical experience, investment, and practical application to translate AI advancements into more accessible and actionable medical services.
The future of AI in healthcare will be determined not only by who develops the most advanced technologies but also by how effectively these technologies can be realized as safe, accessible, and beneficial care. For China and the United States, continued dialogue and practical cooperation may be the path to turning their parallel achievements in AI and healthcare into solutions that benefit patients and healthcare systems on both sides.

